Huntingdon Life Sciences acquires Harlan Laboratories


Creates a leading global contract organisation

Huntingdon Life Sciences, a UK-based contract research organisation, has bought Harlan Laboratories for an undisclosed sum.

The combined company will have two operating divisions: Research Models and Services and Contract Research Services. It will have revenue of around US$500m, providing a strong platform for future growth.

The acquisition creates a leading global organisation offering full service, non-clinical, contract research and research models and services, the company said.

Brian Cass, CEO of Huntingdon Life Sciences, said: \'This acquisition is precisely in line with our strategy to broaden our support for the pharmaceutical, crop protection and chemical industries, as well as universities, government, and other research organisations. Our two companies have a long heritage and together we will maintain and build on our reputation for high quality science and innovation.\'

Sign up for your free email newsletter

Harlan CEO Hans Thunem added: \'Merging these two leading companies, with their complementary product and service offerings, positions the combined organisation as a global leader in supporting the growing market for outsourced research and development.\'